Our own Alvin Chin, Prostate Cancer Survivor & Advocate, Virginia Prostate Coalition, joins oncologists Howard Scher MD, Donald S. Coffey, PhD, Peter S. Nelson, MD and representatives from research and the Pharma industry for a round table discussion April 23. You can make your voice heard by joining the conference by phone and emailing questions [...]
Today I posted the following on the ACOR Prostate listserv. It was in response to a series of emails that complained 1- That the organizations representing the prostate cancer community were at odds with each other and that there are too many prostate organizations. 2- That the prostate cancer community is disorganized and unable to [...]
The following statement about the recent controversy regarding PSA testing was issued this morning by the thirteen organizations , including Malecare A JOINT STATEMENT FROM AMERICA’S PROSTATE CANCER ADVOCACY, EDUCATION, AND SUPPORT ORGANIZATIONS Since 1993, when the PLCO trial was started, we have awaited the results of this trial with eager anticipation, as have others. [...]
Over the last few days the media has been full of debate about the most recent, contradictory studies that have been released about the efficacy of the PSA as a diagnostic tool for prostate cancer. Normally, I would not write about this issue in this blog since those of us with recurrences and advanced prostate [...]
The FDA has issued an emergency warning that certain adhesive patches (transdermal patches) that deliver medication through the skin have been found to be a risk to patients safety while they undergo a magnetic resonance imaging (MRI). If these problem patches are affixed to the skin while actually undergoing the scan they can cause skin [...]